Former GSK exec joins Aclaris Therapeutics as chief medical officer
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Aclaris Therapeutics Inc. appointed David Gordon chief medical officer.
Gordon recently served as senior vice president and head of dermatology research at GlaxoSmithKline PLC.
Wayne, Pa.-based Aclaris Therapeutics develops therapies in the areas of medical and aesthetic dermatology as well as immunology.
